Novo Nordisk A/S announced a share repurchase program on November 11, 2024, expecting to buy back DKK 20 billion worth of shares over the next 12 months, with DKK 3.1 billion targeted from November 11, 2024, to February 3, 2025; as of December 13, 2024, they have already repurchased approximately 22.2 million shares at an average price of DKK 827.52.